The pilot project will evaluate testing performed by multiple laboratories using standardized SOPs of donor/recipient pairs where DSA is present. Samples, custom and commercial reagents will be provided by the Workshop organizers. Testing includes IgG SAB I, IgG SAB II, Bio-C1q SAB I, Bio-C1q SAB II.

This project requires serum & DNA or complete HLA typing information by NGS HLA from donor/recipient pairs, first transplant, single organ (heart or kidney) where DSA is present but outcome data is not available. Solid phase testing to be performed using standardized work shop protocols, custom and commercial reagents including IgG SAB I, IgG SAB II, Bio-C1q SAB I, Bio-C1q SAB II.

Sub-Projects (based on cohort and analysis performed)

This project requires serum, DNA & cells of donor/recipient pairs where DSA present, testing to be performed using standardized SOPs, custom and commercial reagents. Testing includes IgG SAB I, IgG SAB II, Bio-C1q SAB I, Bio-C1q SAB II and DSA-FXM, DNA or complete HLA typing information by NGS HLA from donor/recipient pairs. Analysis: DSA FXM, other FXM methods when available, pre and post-Transplant antibody results and transplant outcomes. Donor pairs may be from Kidney or Heart Transplant pairs but must be single organ primary Transplants.

Project Leader: Dolly Tyan (dtyan@stanford.edu)

This project requires serum & DNA or complete HLA typing information by NGS HLA from donor/recipient pairs, first transplant, single organ (heart or kidney) where DSA present. Graft outcome information is required. Results obtained from various epitope analysis will be compared to solid phase results and NGS HLA typing from donor and recipient. Solid phase testing to be performed using standardized work shop protocols, custom and commercial reagents including IgG SAB I, IgG SAB II, Bio-C1q SAB I, Bio-C1q SAB II.

Sub-Projects (based on cohort and analysis performed)